COLECTOMY IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS

被引:9
|
作者
POST, AB
BOZDECH, JM
LAVERY, I
BARNES, DS
机构
[1] CLEVELAND CLIN FDN,DEPT GASTROENTEROL,CLEVELAND,OH 44195
[2] CLEVELAND CLIN FDN,DEPT COLORECTAL SURG,CLEVELAND,OH 44195
关键词
PRIMARY SCLEROSING CHOLANGITIS; CIRRHOSIS; ULCERATIVE COLITIS; CROHNS DISEASE;
D O I
10.1007/BF02047543
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: The aim of this study was to assess risk factors for early postoperative death in patients with primary sclerosing cholangitis who are undergoing colectomy. METHODS: The charts of 24 patients with primary sclerosing cholangitis who underwent colectomy between 1972 and 1990 at the Cleveland Clinic Foundation were reviewed. Clinical and laboratory data were collected and compiled to determine preoperative factors that might be helpful in predicting early postoperative death. RESULTS: The only factor that predicted a poor outcome was cirrhosis at the time of surgery. Three of 8 patients with cirrhosis and 0 of 16 patients without cirrhosis had an early postoperative death (P < 0.05, Fisher's exact test). CONCLUSION: We conclude that establishing whether or not patients with inflammatory bowel disease and primary sclerosing cholangitis have cirrhosis is helpful in determining the risk of colectomy.
引用
收藏
页码:175 / 178
页数:4
相关论文
共 50 条
  • [31] INFLAMMATORY BOWEL DISEASE (IBD) COMPLICATED BY PRIMARY SCLEROSING CHOLANGITIS (PSC) AND CIRRHOSIS - IS COLECTOMY SAFE?
    Lian, L.
    Kiran, P.
    Shen, B.
    Vogel, J.
    Remzi, F.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 604 - 604
  • [32] Prevalence and phenotype of inflammatory bowel disease in patients with primary sclerosing cholangitis
    Huynh, D.
    Bate, J. P.
    Andrews, J. M.
    Johnson, D.
    Nind, G.
    Harley, Haj
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 48 - 48
  • [33] Endoscopic features of inflammatory bowel disease in patients with primary sclerosing cholangitis
    Smith, Timothy
    Swaroop, Prabhakar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S454 - S454
  • [34] The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
    Lynch K.D.
    Keshav S.
    Chapman R.W.
    Current Hepatology Reports, 2019, 18 (1) : 115 - 126
  • [35] Primary sclerosing cholangitis in Japanese patients: Association with inflammatory bowel disease
    Okada, H
    Mizuno, M
    Yamamoto, K
    Tsuji, T
    ACTA MEDICA OKAYAMA, 1996, 50 (05) : 227 - 235
  • [36] Prevalence and Phenotype of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis
    Huynh, Dep
    Bate, John P.
    Andrews, Jane M.
    Johnson, Richard
    LeMire, Marc
    Nind, Garry
    Harley, Hugh A.
    GASTROENTEROLOGY, 2012, 142 (05) : S991 - S991
  • [37] ASSESSING OUTCOMES OF PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE
    Garg, Kanika
    Eswaran, Sheila L.
    HEPATOLOGY, 2021, 74 : 745A - 746A
  • [38] Colorectal cancer in patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
    Lopez-Panqueva, R. D. P.
    Ortiz-Pereira, M.
    Park Noh, J. H.
    Castillo, C.
    Mendoza de Molano, B.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S97 - S97
  • [39] Inflammatory bowel disease course in patients transplanted for primary sclerosing cholangitis
    Wallack, Ariana
    Levine, Joel S.
    Forman, Lisa
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 287 - 288
  • [40] Primary Sclerosing Cholangitis and Distribution of Inflammatory Bowel Disease
    Feurer, Matthew E.
    Hilden, Kristen
    Adler, Douglas G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (12) : 1418 - 1418